Molecular mechanisms of remodeling in human atrial fibrillation.
暂无分享,去创建一个
Harry J G M Crijns | I. V. Van Gelder | H. Crijns | R. Henning | H. Kampinga | B. Brundel | Harm H Kampinga | Robert H Henning | Isabelle C Van Gelder | Bianca J J M Brundel
[1] D. Green,et al. Stress management - heat shock protein-70 and the regulation of apoptosis. , 2001, Trends in cell biology.
[2] M. Hori,et al. Intracellular calcium level required for calpain activation in a single myocardial cell. , 2001, Journal of molecular and cellular cardiology.
[3] S. Nattel,et al. Dihydropyridine and beta adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation. , 1999, Cardiovascular research.
[4] U Schotten,et al. Cellular Mechanisms of Depressed Atrial Contractility in Patients With Chronic Atrial Fibrillation , 2001, Circulation.
[5] G. Majno,et al. Apoptosis, oncosis, and necrosis. An overview of cell death. , 1995, The American journal of pathology.
[6] B. R. Jewell,et al. Analysis of the effects of changes in rate and rhythm upon electrical activity in the heart. , 1980, Progress in biophysics and molecular biology.
[7] P. Coumel,et al. Failure in the rate adaptation of the atrial refractory period: its relationship to vulnerability. , 1982, International journal of cardiology.
[8] K. Shirato,et al. Mechanisms of coronary microvascular dilation induced by the activation of pertussis toxin-sensitive G proteins are vessel-size dependent. Heterogeneous involvement of nitric oxide pathway and ATP-sensitive K+ channels. , 1997, Circulation research.
[9] M. Allessie,et al. Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. , 2001, Journal of molecular and cellular cardiology.
[10] K. Arakawa,et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. , 2000, Circulation.
[11] S. Huang,et al. Down-regulation of L-type calcium channel and sarcoplasmic reticular Ca(2+)-ATPase mRNA in human atrial fibrillation without significant change in the mRNA of ryanodine receptor, calsequestrin and phospholamban: an insight into the mechanism of atrial electrical remodeling. , 1999, Journal of the American College of Cardiology.
[12] D. Atar,et al. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. , 1997, Circulation research.
[13] Zhang Ml. Calcium activated neutral protease and its endogenous inhibitor , 1998 .
[14] H. Kawasaki,et al. Calcium‐activated neutral protease and its endogenous inhibitor Activation at the cell membrane and biological function , 1987, FEBS letters.
[15] J. Olgin,et al. Inhibition of the Na+/H+ Exchanger Delays the Development of Rapid Pacing–Induced Atrial Contractile Dysfunction , 2001, Circulation.
[16] M. Allessie,et al. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. , 2000, Cardiovascular research.
[17] P. L. Becker,et al. Gs and adenylyl cyclase in transverse tubules of heart: implications for cAMP-dependent signaling. , 1999, American journal of physiology. Heart and circulatory physiology.
[18] M. Rosen,et al. The Relationship of Human Atrial Cellular Electrophysiology to Clinical Function and Ultrastructure , 1983, Circulation research.
[19] F. Di Lisa,et al. Cardiomyocyte troponin T immunoreactivity is modified by cross-linking resulting from intracellular calcium overload. , 1996, Circulation.
[20] H. Crijns,et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. , 1991, The American journal of cardiology.
[21] T. Pham,et al. Effects of left atrial enlargement on atrial transmembrane potentials and structure in dogs with mitral valve fibrosis. , 1982, The American journal of cardiology.
[22] H. Crijns,et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. , 1996, Archives of internal medicine.
[23] D. Atsma,et al. Role of calcium-activated neutral protease (calpain) in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition. , 1995, Circulation research.
[24] S. Nattel,et al. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes. , 2001, Cardiovascular research.
[25] John Calvin Reed,et al. Myocardial cell death in fibrillating and dilated human right atria. , 1999, Journal of the American College of Cardiology.
[26] J A ABILDSKOV,et al. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. , 1959, American heart journal.
[27] C. Pandozi,et al. Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. , 1998, Circulation.
[28] P. Vardas,et al. Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence. , 2000, Cardiovascular research.
[29] D. Green,et al. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. , 1999, Blood.
[30] Douglas L. Jones,et al. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. , 1995, Circulation.
[31] S Nattel,et al. Mathematical analysis of canine atrial action potentials: rate, regional factors, and electrical remodeling. , 2000, American journal of physiology. Heart and circulatory physiology.
[32] L. Tsai,et al. Neurotoxicity induces cleavage of p35 to p25 by calpain , 2000, Nature.
[33] I. V. Van Gelder,et al. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. , 1999, Cardiovascular research.
[34] Z. Papp,et al. Calpain-I induced alterations in the cytoskeletal structure and impaired mechanical properties of single myocytes of rat heart. , 2000, Cardiovascular research.
[35] K. Blomgren,et al. A possible physiological role of the Ca-dependent protease calpain and its inhibitor calpastatin on the Ca current in guinea pig myocytes , 1988, Pflügers Archiv.
[36] M. Allessie,et al. Altered Pattern of Connexin40 Distribution in Persistent Atrial Fibrillation in the Goat , 1998, Journal of cardiovascular electrophysiology.
[37] M. Allessie,et al. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. , 2000, Journal of molecular and cellular cardiology.
[38] M R Franz,et al. Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. , 1997, Journal of the American College of Cardiology.
[39] W. Manning,et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. , 1994, Journal of the American College of Cardiology.
[40] R. Tieleman,et al. Alterations in Gene Expression of Proteins Involved in the Calcium Handling in Patients with Atrial Fibrillation , 1999, Journal of cardiovascular electrophysiology.
[41] F. Di Lisa,et al. Troponin T cross-linking in human apoptotic cardiomyocytes. , 1997, The American journal of pathology.
[42] H. Crijns,et al. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels. , 2001, Journal of the American College of Cardiology.
[43] M. Allessie,et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. , 1995, Circulation.
[44] U Ravens,et al. Molecular Basis of Downregulation of G-Protein–Coupled Inward Rectifying K+ Current (IK,ACh) in Chronic Human Atrial Fibrillation: Decrease in GIRK4 mRNA Correlates With Reduced IK,ACh and Muscarinic Receptor–Mediated Shortening of Action Potentials , 2001, Circulation.
[45] H. Crijns,et al. Endothelin System in Human Persistent and Paroxysmal Atrial Fibrillation , 2001, Journal of cardiovascular electrophysiology.
[46] S Nattel,et al. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. , 1997, Circulation.
[47] A. Goette,et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. , 2000, Circulation.
[48] M. Allessie,et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. , 1997, Circulation.
[49] Simon C Watkins,et al. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. , 1998, Circulation.
[50] F. Morady,et al. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. , 1997, Circulation.
[51] A. Goette,et al. Electrical remodeling in atrial fibrillation. Time course and mechanisms. , 1996, Circulation.
[52] J Haaksma,et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? , 1998, Journal of the American College of Cardiology.
[53] S. Nattel,et al. The T-type Ca(2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. , 1999, Circulation.
[54] J. Olgin,et al. Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. , 2000, Circulation.
[55] M. Courtemanche,et al. Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. , 1998, The American journal of physiology.
[56] M. Zhang. [Calcium activated neutral protease and its endogenous inhibitor]. , 1998, Sheng li ke xue jin zhan [Progress in physiology].
[57] H. C. Burger,et al. Experimental and laboratory reports: Comparison of three different systems of vectorcardiography , 1959 .
[58] A J Levi,et al. Role of Intracellular Sodium Overload in the Genesis of Cardiac Arrhythmias , 1997, Journal of cardiovascular electrophysiology.
[59] C. Zuppan,et al. Mutations of the Connexin43 gap-junction gene in patients with heart malformations and defects of laterality. , 1995, The New England journal of medicine.
[60] A. L. Wit,et al. Mechanisms for atrial arrhythmias associated with cardiomyopathy: a study of feline hearts with primary myocardial disease. , 1984, Circulation.
[61] F. Morady,et al. Short-term effect of atrial fibrillation on atrial contractile function in humans. , 1999, Circulation.
[62] W. Catterall,et al. Differential Proteolysis of the Full‐Length Form of the L‐Type Calcium Channel α1 Subunit by Calpain , 1994, Journal of neurochemistry.
[63] A. Goette,et al. Expression and activity of ectopeptidases in fibrillating human atria. , 2001, Journal of molecular and cellular cardiology.
[64] M. Lerch,et al. Sphincter stencels and gallstone migration through the biliary tract , 1993, The Lancet.
[65] D. Garcia-Dorado,et al. Cardiovascular Research , 1966 .
[66] A. Wear. CIRCULATION , 1964, The Lancet.
[67] J. Nerbonne,et al. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. , 1997, Circulation research.
[68] S H Lee,et al. Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. , 1999, Cardiovascular research.
[69] S. Nattel,et al. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. , 1998, Circulation.
[70] G. Christensen,et al. Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644. , 1996, Circulation.
[71] I. V. Van Gelder,et al. Molecular adaptations in human atrial fibrillation : mechanisms of protein remodeling , 2000 .
[72] R. Hauer,et al. Identification of the substrate of atrial vulnerability in patients with idiopathic atrial fibrillation. , 2000, Circulation.
[73] Marcel Leist,et al. Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.
[74] M. Maki,et al. Calpastatin domain L is involved in the regulation of L-type Ca2+ channels in guinea pig cardiac myocytes. , 2000, Biochemical and biophysical research communications.
[75] M. Allessie,et al. Structural changes of atrial myocardium during chronic atrial fibrillation. , 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[76] J. Nerbonne,et al. Atrial L-type Ca2+ currents and human atrial fibrillation. , 1999, Circulation research.
[77] J. Olgin,et al. Basic mechanisms of atrial fibrillation. , 2004, Cardiology clinics.
[78] S Nattel,et al. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. , 1999, Circulation research.
[79] J. Olgin,et al. Role of the Na(+)/H(+) exchanger in short-term atrial electrophysiological remodeling. , 2000, Circulation.
[80] D. Todd,et al. Reversal of atrial electrical remodeling after cardioversion of persistent atrial fibrillation in humans. , 2000, Circulation.
[81] S. Nattel,et al. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia. , 1998, Circulation.
[82] R. Lane,et al. A comparison of the intracellular distribution of mu-calpain, m-calpain, and calpastatin in proliferating human A431 cells. , 1992, Experimental cell research.
[83] S Nattel,et al. Basic mechanisms of atrial fibrillation--very new insights into very old ideas. , 2000, Annual review of physiology.
[84] Michael R. Rosen,et al. Pathophysiology and Prevention of Atrial Fibrillation , 2001, Circulation.
[85] M. Yano,et al. Alterations in cardiac sarcoplasmic reticulum Ca2+ regulatory proteins in the atrial tissue of patients with chronic atrial fibrillation. , 1999, Journal of the American College of Cardiology.
[86] S Nattel,et al. Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation. , 1999, Cardiovascular research.
[87] R F Bosch,et al. Ionic mechanisms of electrical remodeling in human atrial fibrillation. , 1999, Cardiovascular research.
[88] M. Allessie,et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. , 1997, Circulation.
[89] H. Crijns,et al. Ion Channel Remodeling Is Related to Intraoperative Atrial Effective Refractory Periods in Patients With Paroxysmal and Persistent Atrial Fibrillation , 2001, Circulation.
[90] A. Stracher. Calpain Inhibitors as Therapeutic Agents in Nerve and Muscle Degeneration , 1999, Annals of the New York Academy of Sciences.
[91] M. Allessie,et al. Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation. , 1997, The American journal of pathology.
[92] D P Zipes,et al. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs. Electrophysiological remodeling. , 1996, Circulation.
[93] W. Manning,et al. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. , 1989, Journal of the American College of Cardiology.
[94] S Nattel,et al. Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation. , 1997, Circulation research.
[95] A. Goette,et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. , 2000, Journal of the American College of Cardiology.
[96] S Nattel,et al. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. , 1997, Circulation research.
[97] J. Saffitz,et al. Proteolysis of connexin43-containing gap junctions in normal and heat-stressed cardiac myocytes. , 1998, Cardiovascular research.
[98] C. Tai,et al. Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs. , 1998, Circulation.
[99] S Nattel,et al. Regional and functional factors determining induction and maintenance of atrial fibrillation in dogs. , 1996, The American journal of physiology.
[100] T. Ryan,et al. Safety and efficacy of percutaneous coronary interventions performed immediately after diagnostic catheterization in northern new england and comparison with similar procedures performed later. , 2000, The American journal of cardiology.
[101] S Nattel,et al. Differing sympathetic and vagal effects on atrial fibrillation in dogs: role of refractoriness heterogeneity. , 1997, The American journal of physiology.